Literature DB >> 2547746

Investigation of the structural properties of dihydrophenazines which contribute to their pro-oxidative interactions with human phagocytes.

J E Savage1, J F O'Sullivan, B M Zeis, R Anderson.   

Abstract

Twenty-six dihydrophenazine compounds, including clofazimine, were investigated, at a fixed concentration of 1 mg/l, for their effects on spontaneous and stimulus-activated generation of superoxide by human neutrophils in vitro. The synthetic chemotactic tripeptide N-formyl-L-methionyl-L-leucyl-L phenyl-alanine (FMLP) (0.1 microM) was used as a stimulant of membrane-associated oxidative metabolism. None of the agents tested influenced basal levels of superoxide generation by neutrophils. However sixteen of these compounds, all rimino phenazines, significantly increased the production of superoxide by FMLP-activated neutrophils. These pro-oxidative, priming interactions of the rimino phenazines with neutrophils were largely dependent on the nature of the alkylimino group at position 2 on the phenazine nucleus, and to a lesser extent on halogenation. Cycloalkylimino groups were generally less potent stimulants of superoxide generation by FMLP-activated neutrophils than clofazimine, and their pro-oxidative properties were independent of mono- or dichlorination. However the halogen-free cycloalkylimino compound, B669, was an exceptionally potent pro-oxidative agent. Chlorination was promotive to pro-oxidative activity in the case of dihydrophenazines with linear or branched alkylimino substituents. The pharmaco-therapeutic mechanisms of dihydrophenazines may be related to their pro-oxidative interactions with phagocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547746     DOI: 10.1093/jac/23.5.691

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

Review 1.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 2.  Immunomodulation by antibacterial agents. Is it clinically relevant?

Authors:  M T Labro
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

3.  Antimicrobial activities of clofazimine and B669 are mediated by lysophospholipids.

Authors:  C E Van Rensburg; G K Jooné; J F O'Sullivan; R Anderson
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

4.  The inhibitory effects of Mycobacterium tuberculosis on MHC class II expression by monocytes activated with riminophenazines and phagocyte stimulants.

Authors:  A A Wadee; R H Kuschke; T G Dooms
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

5.  Macrophages sequester clofazimine in an intracellular liquid crystal-like supramolecular organization.

Authors:  Jason Baik; Gus R Rosania
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.